Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

OBJECTIVES/METHODS: This 1-yr prospective phase II trial evaluated the efficacy of deferasirox in regularly transfused patients aged 3–81 yrs with myelodysplastic syndromes (MDS; n = 47), Diamond–Blackfan anaemia (DBA; n = 30), other rare anaemias (n = 22) or β-thalassaemia (n = 85). Dosage was dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Porter, John, Galanello, Renzo, Saglio, Giuseppe, Neufeld, Ellis J, Vichinsky, Elliott, Cappellini, Maria Domenica, Olivieri, Nancy, Piga, Antonio, Cunningham, Melody J, Soulières, Denis, Gattermann, Norbert, Tchernia, Gilbert, Maertens, Johan, Giardina, Patricia, Kwiatkowski, Janet, Quarta, Giovanni, Jeng, Michael, Forni, Gian Luca, Stadler, Michael, Cario, Holger, Debusscher, Louisette, Porta, Matteo Della, Cazzola, Mario, Greenberg, Peter, Alimena, Giuliana, Rabault, Bertrand, Gathmann, Insa, Ford, John Malcolm, Alberti, Daniele, Rose, Christian
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268958/
https://www.ncbi.nlm.nih.gov/pubmed/18028431
http://dx.doi.org/10.1111/j.1600-0609.2007.00985.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268958/
https://www.ncbi.nlm.nih.gov/pubmed/18028431
http://dx.doi.org/10.1111/j.1600-0609.2007.00985.x

Ejemplares similares